Article

Efficacy of SARS-CoV-2 primary and booster vaccine doses in CAR-T recipients

2022-06-29

Abstract excerpt

<title>Abstract</title> <p>While multiple studies have demonstrated diminished humoral response to vaccinations against COVID-19 in immunocompromised patients, data are limited in chimeric antigen receptor T-cell (CAR-T) recipients. In this systematic review, we identified 18 studies through a manual search of key databases that reported SARS-CoV-2 vaccine responses in 236 CAR-T recipients. This included data fro...

Topics

Open a Topic to create a Post that cites this publication.

Identifiers and source

Literature Corpus work: 6d4d4437-ad15-5f90-9850-af4645cf85c0
DOI: 10.21203/rs.3.rs-1778250/v1

Open publication

Related research

Semantic proximity does not establish scientific evidence.

Click a neighbor to travelStep 1 · 12 closest

Efficacy of SARS-CoV-2 primary and booster vaccine doses in CAR-T recipientsDOI 10.21203/rs.3.rs-1778250/v1Read

Efficacy and longevity of immune response to 3 <sup>rd</sup> COVID-19 vaccine and effectiveness of a 4 <sup>th</sup> dose in severely immunocompromised patients with cancerSemantic proximity Read

Cellular and humoral responses to SARS-CoV-2 vaccination in immunosuppressed patientsSemantic proximity Read

Cellular and Humoral Responses to SARS-CoV-2 Vaccination in Immunosuppressed PatientsSemantic proximity Read

Adaptive immunity and neutralizing antibodies against SARS-CoV-2 variants of concern following vaccination in patients with cancer: The CAPTURE studySemantic proximity Read

Early Real-World Evidence on the Relative SARS-CoV-2 Vaccine Effectiveness of Bivalent COVID-19 Booster Doses: a Narrative ReviewSemantic proximity Read

Immunogenicity and Safety of COVID-19 Booster Vaccination: A Real-World Clinical Trial to Identify the Best Vaccination StratagySemantic proximity Read

Seroconversion following the first, second, and third dose of SARS-CoV-2 vaccines in immunocompromised population; A systematic review and meta-analysisSemantic proximity Read

A review of leading COVID-19 vaccines, the quest for immune protection, and its key challenges. Part 3: Covid-19 vaccines – Key challenges and translational scienceSemantic proximity Read

Early real world evidence on the relative SARS-COV-2 vaccine effectiveness of bivalent COVID-19 booster doses: a rapid reviewSemantic proximity Read

Protective Heterologous T Cell Immunity in COVID-19 Induced by MMR and Tdap Vaccine AntigensSemantic proximity Read

Protective heterologous T cell immunity in COVID-19 induced by MMR and Tdap vaccine antigensSemantic proximity Read

The Immunogenicity and Safety of Different COVID-19 Booster Vaccination Following CoronaVac or ChAdOx1 nCoV-19 Primary SeriesSemantic proximity Read